Cargando…
Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy
Management of high-grade gliomas (HGGs) remains a complex challenge with an overall poor prognosis despite aggressive multimodal treatment. New translational research has focused on maximizing tumor cell eradication through improved tumor cell targeting while minimizing collateral systemic side effe...
Autores principales: | Loya, Joshua, Zhang, Charlie, Cox, Emily, Achrol, Achal S, Kesari, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880300/ https://www.ncbi.nlm.nih.gov/pubmed/31747784 http://dx.doi.org/10.2217/cns-2019-0002 |
Ejemplares similares
-
Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
por: Loya, Joshua, et al.
Publicado: (2019) -
Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
por: Mukherjee, Anubhab, et al.
Publicado: (2019) -
Radioimmunotherapy‐induced intratumoral changes in cervical squamous cell carcinoma at single‐cell resolution
por: Liu, Chao, et al.
Publicado: (2022) -
Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II)
por: Giotta Lucifero, Alice, et al.
Publicado: (2021) -
Personalized Medicine in Cerebrovascular Neurosurgery: Precision Neurosurgical Management of Cerebral Aneurysms and Subarachnoid Hemorrhage
por: Achrol, Achal Singh, et al.
Publicado: (2016)